The present study aimed to evaluate the clinical and radiological 1-year outcomes of uterine artery embolization (UAE) performed in a selected population of women with symptomatic myomas and who do not wish to conceive. Between January 2004 and January 2018, a total of 62 patients with pre-menopausal status and with no wish to conceive in the future underwent UAE for the treatment of symptomatic fibroids. All the patients underwent magnetic resonance imaging (MRI) and/or transvaginal ultrasonography (TV-US) before and after the procedure at 1-year follow-up. Clinical and radiological parameters were recorded, stratifying the population into 3 groups according to the size of the dominant myoma (group 1: 80 mm). Mean fibroid diameter was significantly reduced (42.6% & PLUSMN; 21.6%) at 1-year follow-up, with excellent improvements in terms of both symptoms and quality of life. No significant difference was observed regarding baseline dimension and the number of myomas. No major complications were reported (2.5%). The present study confirms the safety and efficacy of UAE in the treatment of symptomatic fibroids in pre-menopausal women with no desire to conceive.

Cappelli, A., Mosconi, C., Cocozza, M.A., Brandi, N., Bartalena, L., Modestino, F., et al. (2023). Uterine Artery Embolization for the Treatment of Symptomatic Uterine Fibroids of Different Sizes: A Single Center Experience. JOURNAL OF PERSONALIZED MEDICINE, 13(6), 1-16 [10.3390/jpm13060906].

Uterine Artery Embolization for the Treatment of Symptomatic Uterine Fibroids of Different Sizes: A Single Center Experience

Mosconi, Cristina;Cocozza, Maria Adriana;Bartalena, Laura;Vara, Giulio;Paccapelo, Alexandro;Villa, Gioia;Seracchioli, Renato;Renzulli, Matteo
2023

Abstract

The present study aimed to evaluate the clinical and radiological 1-year outcomes of uterine artery embolization (UAE) performed in a selected population of women with symptomatic myomas and who do not wish to conceive. Between January 2004 and January 2018, a total of 62 patients with pre-menopausal status and with no wish to conceive in the future underwent UAE for the treatment of symptomatic fibroids. All the patients underwent magnetic resonance imaging (MRI) and/or transvaginal ultrasonography (TV-US) before and after the procedure at 1-year follow-up. Clinical and radiological parameters were recorded, stratifying the population into 3 groups according to the size of the dominant myoma (group 1: 80 mm). Mean fibroid diameter was significantly reduced (42.6% & PLUSMN; 21.6%) at 1-year follow-up, with excellent improvements in terms of both symptoms and quality of life. No significant difference was observed regarding baseline dimension and the number of myomas. No major complications were reported (2.5%). The present study confirms the safety and efficacy of UAE in the treatment of symptomatic fibroids in pre-menopausal women with no desire to conceive.
2023
Cappelli, A., Mosconi, C., Cocozza, M.A., Brandi, N., Bartalena, L., Modestino, F., et al. (2023). Uterine Artery Embolization for the Treatment of Symptomatic Uterine Fibroids of Different Sizes: A Single Center Experience. JOURNAL OF PERSONALIZED MEDICINE, 13(6), 1-16 [10.3390/jpm13060906].
Cappelli, Alberta; Mosconi, Cristina; Cocozza, Maria Adriana; Brandi, Nicolò; Bartalena, Laura; Modestino, Francesco; Galaverni, Maria Cristina; Vara,...espandi
File in questo prodotto:
File Dimensione Formato  
jpm-12023.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 6.76 MB
Formato Adobe PDF
6.76 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/959818
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 2
social impact